Cutting-Edge Cancer Treatments: Advancing Genomic Medicine *RERUN
Genomic medicine is undergoing rapid change after the Japanese public health insurance system began to cover genetic testing in 2019. Cancer patients who meet certain criteria are able to take these tests for a relatively affordable price, and their genetic information is collected in a massive database and analyzed with the help of around 170 hospitals across the country. But challenges remain, with suitable drugs available for only 10% of patients who undergo testing.
"Cancer drugs that specifically target each type of genetic mutation are in development."
"Genomic medicine was worth doing" – a patient's cancer shrank drastically.
A patient who preventively removed her ovaries works to promote genomic medicine.
"Genomic medicine targets individuals. It may not be suitable for some patients."